Clin2
NCT06722950Possibly a fitNot yet recruiting

AC591 to prevent nerve damage from oxaliplatin chemo

Colorectal Adenoma

Treatments studied

Part of Brain & nervous system, Cancer clinical trials.

This trial tests a drug called AC591 to see if it can prevent nerve damage (tingling, numbness, pain) caused by oxaliplatin, a common chemo drug for colorectal cancer. It is for people starting CAPEOX chemo after colon cancer surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old
  • You have colorectal cancer that was surgically removed within the last 3 weeks to 2 months, and you will get CAPEOX chemo (which includes oxaliplatin) for the first time
  • You are in generally good health, with normal blood counts and liver/kidney function
  • You do not have nerve or muscle diseases like Parkinson's or multiple sclerosis
  • You do not have severe diabetic nerve damage or active infections like HIV or uncontrolled hepatitis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07733817Not yet recruiting
Probiotics to prevent nerve damage from colon cancer chemo

This trial tests whether taking probiotics can reduce nerve damage (peripheral neuropathy) caused by oxaliplatin chemotherapy in people with stage III colon cancer. If you are starting chemo soon, this study may help protect your nerves.

Caen, Centre François Baclesse
NCT07365592Recruiting· Phase 1/Phase 2
Neoadjuvant therapy for locally advanced colorectal cancer

This trial tests a combination of chemotherapy, an immunotherapy drug (anti-PD-1 antibody), and sitagliptin before surgery for colorectal cancer that has not spread to other organs. The goal is to see if this approach can shrink the tumor and improve outcomes.

Hangzhou, Zhejiang
NCT05404230Recruiting
Preventing nerve damage from oxaliplatin in the hands and feet

This study looks at ways to prevent numbness or nerve pain in the hands and feet that can happen from oxaliplatin treatment. It includes people with colon or rectal cancer who will be getting standard chemotherapy with capecitabine plus oxaliplatin.

Aalborg
NCT06888843Recruiting· Phase 2
Chemotherapy for colorectal cancer in patients 70+

This trial tests two chemotherapy drugs, capecitabine alone or with oxaliplatin, in people aged 70 or older after surgery for stage III colorectal cancer. The goal is to find out which treatment works better to prevent cancer from coming back.

Nizhny Novgorod
NCT05850130Recruiting
Acupuncture to treat nerve pain from oxaliplatin chemotherapy

This study tests whether acupuncture can reduce nerve pain caused by oxaliplatin chemotherapy in people with gastrointestinal cancers. It may help lessen symptoms like tingling, numbness, or burning that affect hands or feet.

Créteil
NCT06856447Recruiting· Phase 1
Coenzyme Q10 to prevent nerve damage from chemotherapy

This trial tests whether taking coenzyme Q10 (a natural substance) can help prevent nerve damage caused by the chemotherapy drug oxaliplatin in people with stage III colorectal cancer. If successful, it could reduce pain, numbness, or tingling during treatment.

Cairo

Hear when a new Colorectal Adenoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.